Beta interferon: Completed patient accrual in a bioequivalency study designed to show drug manufactured by BGEN is equivalent to drug produced by Dr. Rentschler

Biogen Inc. (BGEN), Cambridge, Mass. Product: Beta interferon Indication: Multiple sclerosis Status: Completed patient accrual in a bioequivalency study designed to show drug manufactured by BGEN is e...